Celularity Inc.CELUNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-41.7%
5Y CAGR-21.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-41.7%/yr
vs +28.1%/yr prior
5Y CAGR
-21.7%/yr
Recent deceleration
Acceleration
-69.9pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.51M | -10.8% |
| 2024 | $17.39M | -42.9% |
| 2023 | $30.46M | -61.1% |
| 2022 | $78.36M | -11.3% |
| 2021 | $88.35M | +67.6% |
| 2020 | $52.71M | +14.5% |
| 2019 | $46.05M | +58.5% |
| 2018 | $29.06M | - |